Study objectives To study the ability of positron emission tomography (PET) using 18-
fluorodeoxyglucose (FDG) to distinguish between benign and malignant disease in …

BACKGROUND: Positron emission tomography (PET) with 18-fluorodeoxyglucose (FDG) is
an accurate method for differentiating benign from malignant disease. The use of FDG-PET …

[F-18-FDG PET for primary diagnosis differential diagnosis of pleural processes]. - Abstract -
Europe PMC Sign in | Create an account https://orcid.org Europe PMC Menu About Tools …

OBJECTIVE. We determined the ability of 18F-fluorodeoxyglucose (FDG) positron emission
tomography (PET) to differentiate benign and malignant pleural effusions in patients with …

Objective: The diagnostic approach to pleural diseases may be difficult. The CT scan, which
is the current diagnostic technique, has limited accuracy both in the differentiation between …

Study objectives The goals of this study were to determine the sensitivity, specificity, and
predictive accuracy of F-18 fluorodeoxyglucose positron emission tomography (PET-FDG) …

Background This study evaluates the accuracy of [18 F] fluorodeoxyglucose positron
emission tomography (18 F-FDG PET) imaging with semi-quantitative analysis for …

Objectives: We sought to define an accurate diagnostic approach for differentiating benign
from malignant pleural effusion on positron emission tomography–computed tomography …

Diagnostic Ability of FDG-PET/CT in the Detection of Maligna... : Medicine Diagnostic Ability of
FDG-PET/CT in the Detection of Malignant Pleural Effusion : Medicine Log in or Register Get …

Objective The aim of our study was to evaluate the role of 18F-FDG PET/CT integrated
imaging in differentiating malignant from benign pleural effusion. Methods A total of 176 …